PharmaShots | Incisive News in 3 Shots

Subscribe Now

TILT Biotherapeutics

TILT Biotherapeutics Reports Results for TILT-123 in P-I Trial for the Treatment of Solid Tumors at SITC 2023

TILT Biotherapeutics Reports Results for TILT-123 in P-I Trial for the Treatment of Solid Tumors at SITC 2023

November 6, 2023

$TILT Biotherapeutic Entered into a Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate TILT-123 for Refractory Non-Small Cell Lung Cancer$

TILT Biotherapeutic Entered into a Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate TILT-123 for Refractory...

September 26, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us